Suchergebnisse - "Motoi, Noriko"

PubPharm (8)

1

Molecular subtypes of lung adenocarcinoma present distinct immune tumor microenvironments

enthalten in: Cancer science | 2024

von Fukuda, H. | Arai, K. | Mizuno, H. | +38

2

Clinicopathological characteristics and molecular analysis of lung cancer associated with ciliated muconodular papillary tumor/bronchiolar adenoma

enthalten in: Pathology international | 2023

von Higashiyama, M. | Motoi, N. | Yotsukura, M. | +9

3

Chaperone-mediated autophagy receptor modulates tumor growth and chemoresistance in non-small cell lung cancer

enthalten in: Cancer science | 2020

von Ichikawa, A. | Fujita, Y. | Hosaka, Y. | +16

4

Immunocytochemistry for predictive biomarker testing in lung cancer cytology

enthalten in: Cancer cytopathology | 2019

von Jain, D. | Nambirajan, A. | Borczuk, A. | +11

CommentIn: Cancer Cytopathol. 2019 May;127(5):278-280. - PMID 31050221

5

High expression of programmed cell death 1 ligand 1 in lung adenocarcinoma is a poor prognostic factor particularly in smokers and wild-type epidermal growth-factor receptor cases

enthalten in: Pathology international | 2017

von Mori, S. | Motoi, N. | Ninomiya, H. | +7

ErratumIn: Pathol Int. 2017 Apr;67(4):234. - PMID 28370983

6

Therapeutic value of lymph node dissection for right middle lobe non-small-cell lung cancer

enthalten in: Journal of thoracic disease | 2016

von Kuroda, H. | Sakao, Y. | Mun, M. | +5

7

Prognostic significance of CpG island methylator phenotype in surgically resected small cell lung carcinoma

enthalten in: Cancer science | 2016

von Saito, Y. | Nagae, G. | Motoi, N. | +10

8

Prognostic impact of bulky swollen lymph nodes in cN1 non-small cell lung cancer patients

enthalten in: Japanese journal of clinical oncology | 2015

von Samejima, J. | Nakao, M. | Matsuura, Y. | +7

1
[1]